[DOI] [PubMed] [Google Scholar] 34.Gilkeson G, Cannon C, Oates J, Reilly C, Goldman D, Petri M
A trial in 150 participants with either ovarian cancer or castration-resistant prostate cancer found no evidence that ALCAR (1g every 3 days) given with the anticancer drug sagopilone (for up to six cycles of treatment) reduced the overall risk of peripheral neuropathy compared to a placebo (90)
SURMOUNT-1 data with tirzepatide show 22.5% weight loss at 72 weeks on the highest dose
Semax does not produce an immediate, dramatic effect the way a stimulant does
It also promotes nerve regeneration after physical transection, meaning it does not just protect neurons from dying but actively supports the regrowth of damaged nerve fibers
Intradiscal injection of SB-01 represents a first-in-class approach to treating chronic discogenic back pain